These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9471401)

  • 1. On the synthesis of platelet-activating factor via acetylation of 1-alkyl-sn-glycero-3-phosphocholine. Formation of structural isomer of PAF in the presence of bases.
    Chupin VV; Ostapenko OV; Klykov VN; Anikin MV; Serebrennikova GA
    Chem Phys Lipids; 1996 Jun; 81(1):35-43. PubMed ID: 9471401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Formation of a structural isomer of platelet activating factor during acetylation of 1-alkyl-sn-glycero-3-phosphocholine].
    Chupin VV; Ostapenko OV; Klykov VN; Anikin MV; Serebrennikova GA
    Bioorg Khim; 1993 Nov; 19(11):1111-21. PubMed ID: 8285924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells.
    Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A
    J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
    Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
    Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
    Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone.
    Bittman R; Witzke NM; Lee TC; Blank ML; Snyder F
    J Lipid Res; 1987 Jun; 28(6):733-8. PubMed ID: 3611974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
    Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of trideuterated O-alkyl platelet activating factor and lyso derivatives.
    Prakash C; Saleh S; Taber DF; Blair IA
    Lipids; 1989 Sep; 24(9):786-92. PubMed ID: 2586235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain.
    Surles JR; Wykle RL; O'Flaherty JT; Salzer WL; Thomas MJ; Snyder F; Piantadosi C
    J Med Chem; 1985 Jan; 28(1):73-8. PubMed ID: 4038418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
    Chepenik KP; Wykle RL
    Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities.
    Baker RR; Chang H
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):351-60. PubMed ID: 9630721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-enzymatic platelet-activating factor formation by acetylated proteins.
    Thanou PG; Tsoukatos DC
    FEBS Lett; 2004 Aug; 573(1-3):11-4. PubMed ID: 15327967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in exocrine glands and its control by secretagogues.
    Söling HD; Fest W
    J Biol Chem; 1986 Oct; 261(30):13916-22. PubMed ID: 3095313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
    O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
    Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyso platelet activating factor (LysoPAF) and its enantiomer. Total synthesis and carbon-13 NMR spectroscopy.
    Murari MP; Murari R; Parthasarathy S; Guy CA; Kumar VV; Malewicz B; Baumann WJ
    Lipids; 1990 Oct; 25(10):606-12. PubMed ID: 2079867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor.
    Blank ML; Cress EA; Snyder F
    Biochem Biophys Res Commun; 1984 Jan; 118(1):344-50. PubMed ID: 6696762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity.
    Blank ML; Smith ZL; Fitzgerald V; Snyder F
    Biochim Biophys Acta; 1995 Feb; 1254(3):295-301. PubMed ID: 7857969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of platelet-activating factor in the guinea-pig heart.
    Triggiani M; Chilton FH
    J Mol Cell Cardiol; 1992 Oct; 24(10):1101-11. PubMed ID: 1479612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells.
    Clay KL; Johnson C; Worthen GS
    Biochim Biophys Acta; 1991 Aug; 1094(1):43-50. PubMed ID: 1909182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of the precursor (lyso-PAF) of platelet-activating factor via a CoA-dependent transacylase.
    Blank ML; Fitzgerald V; Smith ZL; Snyder F
    Biochem Biophys Res Commun; 1995 May; 210(3):1052-8. PubMed ID: 7763233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.